Humacyte

HUMA · NASDAQ

$0.406+$0.0049 (+1.22%)TodayMarket closed ·
Prev close $0.4011

Who owns HUMA

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 22.2% of HUMA’s shares.

  • Fresenius SE & Co. KGaA5.0%
  • Vanguard Capital Management, LLC3.7%
  • Antipodes Partners Limited3.7%
  • Alyeska Investment Group, L.P.2.2%
  • Next 6 largest institutions7.4%
  • All other shareholders77.8%
Top institutional holders of HUMA
HolderShares% of shares
Fresenius SE & Co. KGaA13.60M5.04%
Vanguard Capital Management, LLC10.11M3.75%
Antipodes Partners Limited10.10M3.75%
Alyeska Investment Group, L.P.6.02M2.23%
Davidson Kempner Capital Management LP5.00M1.85%
BlackRock Institutional Trust Company, N.A.4.42M1.64%
Great Point Partners, LLC3.75M1.39%
AQR Capital Management, LLC2.60M0.96%
Geode Capital Management, L.L.C.2.19M0.81%
UBS Financial Services, Inc.2.06M0.76%

Largest mutual fund holders

Top mutual fund holders of HUMA
HolderShares% of shares
Vanguard Total Stock Market Index Fund7.72M2.86%
Antipodes Global Fund Class P3.96M1.47%
Vanguard Extended Market Index Fund2.12M0.79%
iShares Biotechnology ETF1.82M0.67%
Antipodes Global SMID Fund1.13M0.42%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $90.21K (5 trades) and sold $82.29K (2 trades) of HUMA on the open market.

Latest HUMA insider transactions
InsiderTypeSharesValue
Kuznik Paul BrianAward125.00K—
COWARD D SCOTTAward125.00K—
Jones Keith AnthonyBuy10.00K$5.62K
Jones Keith AnthonyBuy10.00K$6.93K
Jones Keith AnthonyBuy30.00K$17.82K
Wallace Max N.Award80.00K—
Niklason Laura EAward80.00K—
Jones Keith AnthonyAward80.00K—
Green Charles BruceAward80.00K—
Seimetz DianeAward80.00K—

Short interest

Settled Sep 30, 2026

Shares short
29.40M
Days to cover
7.31
% of shares outstanding
10.90%
Average daily volume
4.02M
Change since last report
−7.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.